1. Home
  2. IVA vs REKR Comparison

IVA vs REKR Comparison

Compare IVA & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • REKR
  • Stock Information
  • Founded
  • IVA 2011
  • REKR 2017
  • Country
  • IVA France
  • REKR United States
  • Employees
  • IVA N/A
  • REKR N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • REKR Telecommunications Equipment
  • Sector
  • IVA Health Care
  • REKR Telecommunications
  • Exchange
  • IVA Nasdaq
  • REKR Nasdaq
  • Market Cap
  • IVA 359.6M
  • REKR 153.5M
  • IPO Year
  • IVA 2020
  • REKR N/A
  • Fundamental
  • Price
  • IVA $3.28
  • REKR $1.18
  • Analyst Decision
  • IVA Strong Buy
  • REKR
  • Analyst Count
  • IVA 4
  • REKR 0
  • Target Price
  • IVA $10.50
  • REKR N/A
  • AVG Volume (30 Days)
  • IVA 29.1K
  • REKR 6.8M
  • Earning Date
  • IVA 03-26-2025
  • REKR 08-13-2025
  • Dividend Yield
  • IVA N/A
  • REKR N/A
  • EPS Growth
  • IVA N/A
  • REKR N/A
  • EPS
  • IVA N/A
  • REKR N/A
  • Revenue
  • IVA $14,591,573.00
  • REKR $45,448,000.00
  • Revenue This Year
  • IVA $15.38
  • REKR $8.68
  • Revenue Next Year
  • IVA $24.22
  • REKR $21.45
  • P/E Ratio
  • IVA N/A
  • REKR N/A
  • Revenue Growth
  • IVA N/A
  • REKR 17.97
  • 52 Week Low
  • IVA $1.53
  • REKR $0.62
  • 52 Week High
  • IVA $4.05
  • REKR $2.67
  • Technical
  • Relative Strength Index (RSI)
  • IVA 43.23
  • REKR 46.20
  • Support Level
  • IVA $3.00
  • REKR $1.08
  • Resistance Level
  • IVA $3.47
  • REKR $1.27
  • Average True Range (ATR)
  • IVA 0.24
  • REKR 0.10
  • MACD
  • IVA -0.04
  • REKR -0.03
  • Stochastic Oscillator
  • IVA 20.10
  • REKR 14.29

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About REKR Rekor Systems Inc.

Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.

Share on Social Networks: